协作小组个体患者数据的荟萃分析- 2017耐多药结核病治疗,Ahmad N, Ahuja SD, Akkerman噢,Alffenaar JC,安德森低频,Baghaei P,爆炸D,巴里点,巴斯托斯ML, Behera D,趣事,Bisson GP, Boeree MJ,阀盖,Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP,好像R,陈PC,陈,Chang KC,查尔斯M, Cirule, Dalcolmo MP, D 'Ambrosio L,德弗里斯克Dheda K,提出,洪水J福克斯GJ, Frechet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT,顾年代,Guglielmetti L,霍尔兹TH,休斯J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee年代,汗FA, Kipiani M, Koenig SP, Koh WJ, Kritski, Kuksa L, Kvasnovsky CL,夸克N,局域网Z,兰格C, Laniado-Laborin R,李米,Leimane V,梁CC,梁EC,李PZ Lowenthal P,马舍尔埃尔,标志着SM,激射微波年代,Mbuagbaw L, Migliori GB,脚触V,米勒AC,米特尼克CD, Modongo C,莫尔E, Monedero我Nahid P, Ndjeka N, O ' donnell先生,Padayatchi N, Palmero D,佩普JW, Podewils LJ,雷诺兹,Riekstina V,罗伯特•JRodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P,Tiberi小号,Trajman A,潮L,Udwadia ZF,范德华WERF TS,Veziris N,Viiklepp P,Vilbrun SC,沃尔什K,WestenhouseĴ,紫杉WW,阎JJ,Zetola NM,Zignol男,孟席斯D.
柳叶刀。2018 09月08日; 392(10150):821-834。DOI:10.1016 / S0140-6736(18)31644-1。审查。